Yu, H. A. (2018). Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationYu, H. A. Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationYu, H. A. Concurrent Alterations in EGFR-Mutant Lung Cancers Associated with Resistance to EGFR Kinase Inhibitors and Characterization of MTOR as a Mediator of Resistance. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.